IEBBA, VALERIO
 Distribuzione geografica
Continente #
NA - Nord America 4.091
AS - Asia 2.961
EU - Europa 2.427
SA - Sud America 529
AF - Africa 58
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.085
Nazione #
US - Stati Uniti d'America 3.957
SG - Singapore 953
CN - Cina 732
IT - Italia 640
BR - Brasile 412
HK - Hong Kong 366
NL - Olanda 307
FR - Francia 301
VN - Vietnam 297
SE - Svezia 287
BD - Bangladesh 158
PL - Polonia 158
KR - Corea 135
RU - Federazione Russa 116
DE - Germania 112
GB - Regno Unito 82
BG - Bulgaria 78
FI - Finlandia 78
IE - Irlanda 78
CA - Canada 77
IN - India 77
JP - Giappone 46
ES - Italia 42
MX - Messico 37
AR - Argentina 34
BE - Belgio 30
ID - Indonesia 22
AT - Austria 20
EC - Ecuador 20
SA - Arabia Saudita 20
ZA - Sudafrica 19
TR - Turchia 16
AU - Australia 15
CO - Colombia 15
IL - Israele 15
IQ - Iraq 15
MA - Marocco 13
TW - Taiwan 13
CZ - Repubblica Ceca 12
PK - Pakistan 12
UA - Ucraina 12
IR - Iran 11
CH - Svizzera 10
CL - Cile 10
DK - Danimarca 10
PY - Paraguay 10
VE - Venezuela 10
PT - Portogallo 9
EG - Egitto 8
LV - Lettonia 8
RO - Romania 8
TH - Thailandia 8
AE - Emirati Arabi Uniti 7
DZ - Algeria 7
MY - Malesia 7
PE - Perù 7
PH - Filippine 7
UY - Uruguay 7
GE - Georgia 6
LB - Libano 6
AL - Albania 4
AZ - Azerbaigian 4
BO - Bolivia 4
HU - Ungheria 4
KE - Kenya 4
KZ - Kazakistan 4
NP - Nepal 4
UZ - Uzbekistan 4
BB - Barbados 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
MT - Malta 3
OM - Oman 3
RS - Serbia 3
TT - Trinidad e Tobago 3
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
JO - Giordania 2
LU - Lussemburgo 2
MD - Moldavia 2
MK - Macedonia 2
SI - Slovenia 2
SN - Senegal 2
SV - El Salvador 2
TN - Tunisia 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
EE - Estonia 1
EU - Europa 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
LT - Lituania 1
LY - Libia 1
Totale 10.076
Città #
Singapore 661
Ashburn 435
Fairfield 357
Hong Kong 340
San Jose 311
Santa Clara 291
Amsterdam 245
Beijing 190
Woodbridge 179
Houston 165
Seattle 157
Wilmington 140
Princeton 124
Chandler 120
Seoul 118
Cambridge 112
Council Bluffs 99
Ho Chi Minh City 99
Ann Arbor 92
Chicago 88
Trieste 84
Boardman 81
Sofia 76
Dublin 74
Warsaw 72
Zgierz 69
Lauterbourg 68
Columbus 66
New York 64
Hanoi 62
Moscow 61
Los Angeles 60
Helsinki 55
Milan 53
Jacksonville 50
Paris 41
The Dalles 41
Frankfurt am Main 34
Dallas 33
Redmond 32
São Paulo 32
Rome 31
San Diego 27
London 26
Montreal 26
Shanghai 26
Nanjing 24
Brussels 22
Lappeenranta 22
Nuremberg 22
Tokyo 21
Toronto 21
Hefei 20
Groningen 18
Rio de Janeiro 18
Changsha 17
Hangzhou 17
Guangzhou 16
Naples 16
Da Nang 15
Somerville 15
Turin 15
Florence 14
Munich 14
Buffalo 13
Vienna 13
Brooklyn 12
Dong Ket 12
Orem 12
Pune 12
Mexico City 11
Tianjin 11
Barcelona 10
Haiphong 10
Phoenix 10
Redwood City 10
Bologna 9
Chennai 9
Gainesville 9
Guayaquil 9
Manchester 9
Miano 9
Stockholm 9
Verona 9
Atlanta 8
Biên Hòa 8
Riga 8
Riyadh 8
Salt Lake City 8
Suzhou 8
Denver 7
Düsseldorf 7
Johannesburg 7
Lyon 7
San Francisco 7
Sydney 7
Belo Horizonte 6
Boston 6
Bình Dương 6
Cairo 6
Totale 6.316
Nome #
Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients 710
Eubiosis and dysbiosis: the two sides of the microbiota 377
Uncovering oral Neisseria tropism and persistence using metagenomic sequencing. 366
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer 348
Faecal microbiota composition is related to response to CDK4/6-inhibitors in metastatic breast cancer: A prospective cross-sectional exploratory study 325
Cancer induces a stress ileopathy depending on B-adrenergic receptors and promoting dysbiosis that contribute to carcinogenesis 324
Outbreak of Achromobacter xylosoxidans in an Italian Cystic fibrosis center: genome variability, biofilm production, antibiotic resistance, and motility in isolated strains 219
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade 212
What is new about diet in hepatic encephalopathy 202
Bacterial biofilm in salivary gland stones: Cause or consequence? 192
Exposure of E. coli to DNA-methylating agents impairs biofilm formation and invasion of eukaryotic cells via down regulation of the N-acetylneuraminate lyase NanA 191
Bacterial ratchet motors 175
Lactobacillus iners and gasseri, Prevotella bivia and HPV Belong to the Microbiological Signature Negatively Affecting Human Reproduction 166
Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage 165
Dominant Mucosa-Associated Microbiota in Celiac Children At Diagnosis and After GFD 160
Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer 158
Bdellovibrio bacteriovorus directly attacks Pseudomonas aeruginosa and Staphylococcus aureus Cystic fibrosis isolates 156
Characterization of mucosa-associated and fecal microbiota of children with austism spectrum disorder 148
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Allelic Variants Relate to Shifts in Faecal Microbiota of Cystic Fibrosis Patients 146
Behaviour of Bdellovibrio bacteriovorus in the presence of Gram-positive Staphylococcus aureus 145
A potential role of Escherichia coli pathobionts in the pathogenesis of pediatric inflammatory bowel disease 141
Short-chain fatty acids promote the effect of environmental signals on the gut microbiome and metabolome in mice 141
Dominant genotypes in mucosa-associated Escherichia coli strains from pediatric patients with inflammatory bowel disease 139
Achromobacter xylosoxidans Genomic Characterization and Correlation of Randomly Amplified Polymorphic DNA Profiles of Cystic Fibrosis Patients 138
Correlazione tra presenza di virus influenzali e aumento di E. coli in campioni bioptici prelevati da pazienti pediatrici con morbo di Crohn 133
Strategie terapeutiche innovative basate sulla duplice attività, antibatterica e probiotica, del predatore batterico Bdellovibrio bacteriovorus 133
Escherichia coli Population-Based Study in Pediatric Crohn’s Disease 129
Combining Amplicon Sequencing and Metabolomics in Cirrhotic Patients Highlights Distinctive Microbiota Features Involved in Bacterial Translocation, Systemic Inflammation and Hepatic Encephalopathy 129
Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade 129
Protective role of postbiotic mediators secreted by Lactobacillus rhamnosus GG versus Lipopolysaccharide-induced damage in human colonic smooth muscle cells 125
A distinctive 'microbial signature' in celiac pediatric patients 124
Gut microbiota related to Giardia duodenalis, Entamoeba spp. and Blastocystis hominis infections in humans from Côte d'Ivoire 124
OP-3 The protective role of Lactobacillus Rhamnosus GG-derived factors against LPS-induced damage of human colonic smooth muscle cells 123
Diffusion of meticillin-resistant Staphylococcus aureus USA300 strains in central Italy 122
Microevolution in fimH gene of mucosa-associated Escherichia coli strains isolated from pediatric patients with inflammatory bowel disease 120
Profiling of Oral Microbiota and Cytokines in COVID-19 Patients 120
Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment 120
JC VIRAL REACTIVATION IN A PEDIATRIC PATIENT WITH CROHN'S DISEASE 117
Mo1927 Mucosa-Associated Microbiota and Promoter Methylation Status of Genes Involved in Immune Response in Crohn's Disease Patients 116
Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis 116
Rebuilding the gut microbiota ecosystem 113
Characterization of mucosa-associated and fecal microbiota of children with autism spectre disorder 112
Influence of oral conditions on colonization by highly toxigenic Staphylococcus aureus strains 112
Higher Prevalence and Abundance of Bdellovibrio bacteriovorus in the Human Gut of Healthy Subjects 111
GUT MICROBIOTA AND THE IMMUNE SYSTEM: AN INTIMATE PARTNERSHIP IN HEALTH AND DISEASE 110
Microbiological and molecular characterization of nosocomial and community Staphylococcus aureus isolates 104
Achromobacter xilosoxidans characteristics important for lung colonization of cystic fibrosis (CF) patients 101
Effect of lactoferricin on fluoroquinolone susceptibility of uropathogenic Escherichia coli 101
Fecal Microbial Transplantation Impact on Gut Microbiota Composition and Metabolome, Microbial Translocation and T-lymphocyte Immune Activation in Recurrent Clostridium Difficile Infection Patients 101
Structural Variations of Vaginal and Endometrial Microbiota: Hints on Female Infertility 98
Swimming with an image 96
Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis 95
Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in fecal microbiota of cystic fibrosis patients 95
MICROBIOTA COMPOSITION, METABOLIC PROFILES AND INFLAMMATORY HOST RESPONSE AFTER FECAL MICROBIOTA TRANSPLANTATION (FMT) FOR RECURRENT CLOSTRIDIUM DIFFICILE INFECTION. DOES PROTEOBACTERIA ABUNDANCE PREDICT THE RESPONSE TO FMT? 89
Swimming and rafting of E.coli microcolonies at air–liquid interfaces 89
The predatory bacterium Bdellovibrio bacteriovorus is mucosa associated in healthy pediatrics patients and absent under inflammatory conditions 87
Postbiotic Protective Activity of Lactobacillus Rhamnosus GG-Derived Factors on Pathogen Lipopolysaccharide (LPS)-Induced Damage of Human Colonic Smooth Muscle 86
VIRULENCE TRAITS IN ESCHERICHIA COLI STRAINS ISOLATED FROM OUTPATIENTS WITH URINARY TRACT INFECTIONS 86
Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome 83
Plasmid-mediated fluoroquinolone resistance determinants in Escherichia coli from community uncomplicated urinary tract infection in an area of high prevalence of quinolone resistance 83
Optimizing an array of self adapted temperature modulated metal oxide sensors for biomedical application 79
Molecular characterization of intestinal mucosa-associated escherichia col 78
Ileal immune tonus is a prognosis marker of proximal colon cancer in mice and patients 78
High abundance of genus Prevotella is associated with dysregulation of IFN-I and T cell response in HIV-1-infected patients 73
Molecular characterization of fecal microbiota and metabolic profiles association in cystic fibrosis patients 72
Iron capture through CD71 drives perinatal and tumor-associated Treg expansion 71
Multifaceted modes of action of the anticancer probiotic Enterococcus hirae 71
Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients 70
Metabolic Tumor Volume Assessed by 18F FDG-PET CT Scan as a Predictive Biomarker for Immune Checkpoint Blockers in Advanced NSCLC and Its Biological Correlates 54
Assessment of adhering and invading properties of Escherichia coli strains 54
Does gut microbiota dysbiosis impact the metabolic alterations of hydrogen sulfide and lanthionine in patients with chronic kidney disease? 42
Surrogate markers of intestinal dysfunction associated with survival in advanced cancers 42
Impact of the ONCOBIOME network in cancer microbiome research 39
Navigating the complex relationship between human gut microbiota and breast cancer: Physiopathological, prognostic and therapeutic implications 38
Bacterial predators and BALOs: Growth protocol and relation with mitochondria 33
Achromobacter xylosoxidans genomic characterization and correlation of randomly amplified polymorphic DNA profiles with relevant clinical features of cystic fibrosis patients (Journal of Clinical Microbiology (2010) 48, 4, (1035-1039)) 33
Fecal or bacterial transplantation in mice transfer environment-induced brain plasticity and associated behavioral changes 31
Muribaculum intestinale negatively impacts glioma growth in mice through the toll-like receptor 2 15
Gut dysbiosis in oncology: a risk factor for immunoresistance 8
Totale 10.357
Categoria #
all - tutte 32.911
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.911


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021101 0 0 0 0 0 0 0 0 0 0 0 101
2021/2022736 54 47 18 50 14 36 26 124 95 57 31 184
2022/2023731 90 98 92 23 81 105 18 66 91 24 33 10
2023/2024635 20 28 17 21 35 52 64 214 9 33 55 87
2024/20252.242 45 299 385 126 237 218 163 116 160 208 141 144
2025/20264.503 418 209 312 480 276 281 432 259 589 708 320 219
Totale 10.357